Evotec SE, DE0005664809

Evotec stock: EUR 2.71, down 0.73% premarket

Published on 11/20/2026 at 07:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Evotec develops drug candidates and drug-discovery technologies with pharmaceutical and biotechnology partners. On Xetra, the stock closed at EUR 2.73 on Thursday, November 19, 2026.

Evotec business and market setting

  • Evotec combines drug research, advanced technology and AI-driven innovation with partnerships in pharmaceutical and biotechnology development.
  • Its strategy includes drug discovery and development as well as biologics manufacturing through Just - Evotec Biologics.
Evotec SE, DE0005664809, Illustration mit AI erstellt.

Evotec stock traded at 2.71 euros on Lang & Schwarz at 07:47 CET on Friday, November 20, 2026, 0.73 percent below the Xetra close of Thursday, November 19.

Evotec develops drug candidates and drug-discovery technologies with pharmaceutical and biotechnology partners, according to Evotec.

European equities provide the broader market backdrop through current market reports.

More news and analyses on Evotec stock.

Disclaimer...
en | DE0005664809 | EVOTEC SE | boerse | 70538853 | bgmi